Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
weight loss
Biotech
BioAge inks option agreement for Chinese biotech's obesity asset
BioAge and JiKang Therapeutics will work together to bring the APJ agonist nanobody to the beginning of IND-enabling studies.
Darren Incorvaia
Jun 3, 2025 2:06pm
Ascletis slashes funds for former core programs in obesity pivot
Mar 26, 2025 10:00am
Mira seeks to buy Skny for obesity, smoking cessation asset
Mar 24, 2025 10:08am
Amgen’s late-stage obesity trials expected to read out in ‘27
Mar 5, 2025 1:58pm
Kallyope links oral obesity combo to 3% weight loss at Week 13
Feb 27, 2025 10:17am
Lilly's next focus: Testing incretins in neuro, immunology fields
Feb 6, 2025 2:35pm
